These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
688 related articles for article (PubMed ID: 33292085)
1. Depicting the inhibitory potential of polyphenols from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085 [TBL] [Abstract][Full Text] [Related]
2. Identification of polyphenols from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411 [TBL] [Abstract][Full Text] [Related]
3. Deciphering inhibitory activity of marine algae Ecklonia cava phlorotannins against SARS CoV-2 main protease: A coupled in-silico docking and molecular dynamics simulation study. Chakraborty A; Ghosh R; Barik S; Mohapatra SS; Biswas A; Chowdhuri S Gene; 2024 Oct; 926():148620. PubMed ID: 38821329 [TBL] [Abstract][Full Text] [Related]
4. Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Apr; 40(6):2647-2662. PubMed ID: 33140695 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613 [TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study. Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Mar; 40(5):2053-2066. PubMed ID: 33094701 [TBL] [Abstract][Full Text] [Related]
7. Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective. Chakraborty A; Ghosh R; Soumya Mohapatra S; Barik S; Biswas A; Chowdhuri S Gene; 2024 Sep; 922():148553. PubMed ID: 38734190 [TBL] [Abstract][Full Text] [Related]
8. Biflavonoids from Lokhande K; Nawani N; K Venkateswara S; Pawar S J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454 [TBL] [Abstract][Full Text] [Related]
9. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Abdizadeh R; Hadizadeh F; Abdizadeh T Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728 [TBL] [Abstract][Full Text] [Related]
10. Identification of alkaloids from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Mol Struct; 2021 Apr; 1229():129489. PubMed ID: 33100380 [TBL] [Abstract][Full Text] [Related]
11. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
12. Some Flavolignans as Potent Sars-Cov-2 Inhibitors Cetin A Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852 [TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro. Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056 [TBL] [Abstract][Full Text] [Related]
14. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698 [TBL] [Abstract][Full Text] [Related]
15. Discovery of potential inhibitors targeting SARS-CoV-2 Mpro. Zhou WW; Li DS; Chen Y; You BQ; Zheng YF; Li Y; Si SY; Zhang J Eur Rev Med Pharmacol Sci; 2024 Sep; 28(18):4313-4325. PubMed ID: 39359203 [TBL] [Abstract][Full Text] [Related]
16. An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease. Sigurdardóttir S; Silva SF; Tiukova I; Alalam H; King RD; Grøtli M; Eriksson LA; Sunnerhagen P Microbiol Spectr; 2024 Oct; 12(10):e0124924. PubMed ID: 39162260 [TBL] [Abstract][Full Text] [Related]
17. In silico screening of potential inhibitors from Cordyceps species against SARS-CoV-2 main protease. Deshmukh N; Talkal R; Lakshmi B J Biomol Struct Dyn; 2024 Jun; 42(9):4395-4411. PubMed ID: 37325819 [TBL] [Abstract][Full Text] [Related]
18. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors. Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303 [TBL] [Abstract][Full Text] [Related]
19. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design. Yu W; Wu X; Zhao Y; Chen C; Yang Z; Zhang X; Ren J; Wang Y; Wu C; Li C; Chen R; Wang X; Zheng W; Liao H; Yuan X Molecules; 2021 Dec; 26(23):. PubMed ID: 34885967 [TBL] [Abstract][Full Text] [Related]
20. Insight into crystal structures and identification of potential styrylthieno[2,3- El Bakri Y; Ahmad B; Saravanan K; Ahmad I; Bakhite EA; Younis O; Al-Waleedy SAH; Ibrahim OF; Nafady A; Mague JT; Mohamed SK J Biomol Struct Dyn; 2024 May; 42(8):4325-4343. PubMed ID: 37318002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]